Barcelona-based Grifols, a producer of plasma-based medicines, plans to spend $150 million on expanding and upgrading its plasma facility in Montreal in a deal that could see the province of Quebec provide up to $36 million in funding.
Barcelona-based Grifols, a producer of plasma-based medicines, plans to spend $150 million on expanding and upgrading its plasma facility in Montreal in a deal that could see the province of Quebec provide up to $36 million in funding.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In